INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/INSTITUTIONAL INVESTOR MEET21-07-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/INSTITUTIONAL INVESTOR MEETINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/INSTITUTIONAL INVESTOR MEETINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Board Meeting NoticeINDOCO REMEDIES LTD. - 532612 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 30/06/2022
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve Unaudited standalone & consolidated financial results for the quarter ended 30/06/2022INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
CONFIRMATION CERTIFICATE UNDER REG 74(5) OF SEBI (D& P) REG, ,2018INDOCO REMEDIES LTD. - 532612 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JAYSHANKAR MENONDesignation :- Company Secretary and Compliance OfficerINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/INSTITUTIONAL INVESTORS MEETINDOCO REMEDIES LTD. - 532612 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Incorporation Of A Wholly Owned Subsidiary Company
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Incorporation of a Wholly Owned Subsidiary CompanyINDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
INTIMATION OF SCHEDULE OF ANALYST/INSTITUTIONAL INVESTORS MEET